PDIA3 was found to be upregulated in gliomas and related to suppressive tumor microenvironment, indicating that PDIA3 might be a potential prognostic biomarker or therapy target in the clinical treatment of gliomas. The gene discussed is PDIA3; the disease is neoplasm.